Home NDC 67296-1625
Acyclovir
Product NDC 67296-1625
11-digit product format 672961625
Labeler code 67296
Product ID 67296-1625_b8d08b7b-cbf6-9efd-e053-2995a90a89e7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form TABLET
Route ORAL
Labeler RedPharm Drug, Inc.
Application ANDA202168
Marketing category ANDA
Marketing start 2019-01-01
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67296-1625-2 Acyclovir 20 in 1 BOTTLE TABLET 20 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67296-1625 ACYCLOVIR TABLET [REDPHARM DRUG, INC.] 2 Legacy NDC, 1 package rows 20210114_888c4158-8b15-aa4f-e053-2a95a90a14fd.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67296-1625-2 67296162502 20 TABLET in 1 BOTTLE (67296-1625-2) 20 tablet 2019-01-01 0000-00-00 No No Current